Robert Patrick Mahoney - Aug 14, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role: Chief Scientific Officer
Signature: /s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol: CMRA
Transactions as of: Aug 14, 2023
Transactions value $: $12,504
Form type: 4
Date filed: 8/15/2023, 04:15 PM
Previous filing: Feb 16, 2023
Next filing: Sep 28, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRA	Common Stock	Purchase	$12.5K	+20K	+19.12%	$0.63	125K	Aug 14, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.59 to $0.64, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Content

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.59 to $0.64, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.